Sign in

CIK 0001034842

  • Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943248524
Phone
+1 650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 25,000 shares (grant or award)
  2. 4 Open-market sale CEO, President sold 20,340 shares at $1.75 ($35,595)
  3. 4 Open-market sale EVP, Chief Commercial Officer sold 5,388 shares at $1.66 ($8,945)
  4. 4 Open-market sale EVP & Chief Financial Officer sold 5,389 shares at $1.66 ($8,946)
  5. 4 Open-market sale EVP & CMO sold 5,389 shares at $1.66 ($8,946)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award EVP & Chief Financial Officer acquired 63,000 shares (grant or award)
  9. 4 Grant or award EVP, Chief Commercial Officer acquired 80,000 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy CEO, President bought 1,000,000 shares at $0.69 ($688,400)
  19. 4 Grant or award Director acquired 25,000 shares (grant or award)
  20. 4 Grant or award Director acquired 25,000 shares (grant or award)

Page 6 of 34 · 664 filings